Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-04-05
2011-04-05
Saunders, David A (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C435S007400, C435S007920, C435S023000, C436S086000
Reexamination Certificate
active
07919264
ABSTRACT:
The invention provides a method for determining the efficacy of a TNFα inhibitor, such as a TNFα antibody, or an antigen-binding portion thereof, for treating ankylosing spondylitis (AS), using a collagen degradation biomarker and/or a synovitis biomarker.
REFERENCES:
patent: 5656272 (1997-08-01), Le et al.
patent: 6090382 (2000-07-01), Salfeld et al.
patent: 6153732 (2000-11-01), Eyre
patent: 6258562 (2001-07-01), Salfeld et al.
patent: 6448380 (2002-09-01), Rathjen
patent: 6451983 (2002-09-01), Rathjen
patent: 6498237 (2002-12-01), Rathjen
patent: 6506607 (2003-01-01), Shyjan
patent: 6509015 (2003-01-01), Salfeld et al.
patent: 6607879 (2003-08-01), Cocks et al.
patent: 7070775 (2006-07-01), Le
patent: 7192584 (2007-03-01), Le
patent: 7223394 (2007-05-01), Salfeld et al.
patent: 7250165 (2007-07-01), Heavner
patent: 7276239 (2007-10-01), Le
patent: 7541031 (2009-06-01), Salfeld et al.
patent: 7588761 (2009-09-01), Salfeld et al.
patent: 2003/0012786 (2003-01-01), Teoh et al.
patent: 2003/0049725 (2003-03-01), Heavner
patent: 2003/0161828 (2003-08-01), Abdelghany et al.
patent: 2003/0206898 (2003-11-01), Fischkoff et al.
patent: 2003/0219438 (2003-11-01), Salfeld et al.
patent: 2003/0235585 (2003-12-01), Fischkoff et al.
patent: 2004/0009172 (2004-01-01), Fischkoff et al.
patent: 2004/0033228 (2004-02-01), Krause et al.
patent: 2004/0120952 (2004-06-01), Knight
patent: 2004/0126372 (2004-07-01), Banerjee et al.
patent: 2004/0126373 (2004-07-01), Banerjee et al.
patent: 2004/0131614 (2004-07-01), Banerjee et al.
patent: 2004/0136989 (2004-07-01), Banerjee et al.
patent: 2004/0136990 (2004-07-01), Banerjee et al.
patent: 2004/0136991 (2004-07-01), Banerjee et al.
patent: 2004/0151722 (2004-08-01), Banerjee et al.
patent: 2004/0166111 (2004-08-01), Kaymakcalan et al.
patent: 2004/0203072 (2004-10-01), Sandell et al.
patent: 2004/0219142 (2004-11-01), Banerjee et al.
patent: 2005/0123541 (2005-06-01), Heavner
patent: 2005/0249735 (2005-11-01), Le
patent: 2006/0009385 (2006-01-01), Hoffman et al.
patent: 2006/0018907 (2006-01-01), Le
patent: 2006/0083741 (2006-04-01), Hoffman et al.
patent: 2006/0149042 (2006-07-01), Konstantinov
patent: 2006/0153846 (2006-07-01), Krause et al.
patent: 2006/0246073 (2006-11-01), Knight
patent: 2006/0269479 (2006-11-01), Colton et al.
patent: 2007/0003548 (2007-01-01), Heavner
patent: 2007/0041905 (2007-02-01), Hoffman et al.
patent: 2007/0071747 (2007-03-01), Hoffman et al.
patent: 2007/0081996 (2007-04-01), Hoffman
patent: 2007/0172475 (2007-07-01), Matheus
patent: 2007/0172897 (2007-07-01), Maksymowych et al.
patent: 2007/0184045 (2007-08-01), Doctor
patent: 2007/0196373 (2007-08-01), Le
patent: 2007/0202051 (2007-08-01), Schuschnig
patent: 2007/0202104 (2007-08-01), Banerjee et al.
patent: 2007/0237831 (2007-10-01), Sung et al.
patent: 2007/0269463 (2007-11-01), Donavan
patent: 2007/0292442 (2007-12-01), Wan et al.
patent: 2007/0298040 (2007-12-01), Le
patent: 2008/0025976 (2008-01-01), Le
patent: 2008/0118496 (2008-05-01), Medich et al.
patent: 2008/0131374 (2008-06-01), Medich et al.
patent: 2008/0166348 (2008-07-01), Kupper et al.
patent: 2008/0193466 (2008-08-01), Banerjee et al.
patent: 2008/0227136 (2008-09-01), Pla et al.
patent: 2008/0311043 (2008-12-01), Hoffman et al.
patent: 2009/0017472 (2009-01-01), Stuhlmuller et al.
patent: 2009/0028794 (2009-01-01), Medich et al.
patent: 2009/0110679 (2009-04-01), Li et al.
patent: 2009/0123378 (2009-05-01), Wong et al.
patent: 2009/0155205 (2009-06-01), Salfeld et al.
patent: 2009/0226530 (2009-09-01), Lassner et al.
patent: 2009/0239259 (2009-09-01), Hsieh et al.
patent: 2009/0258018 (2009-10-01), Medich et al.
patent: 2009/0271164 (2009-10-01), Peng et al.
patent: 2009/0291062 (2009-11-01), Fraunhofer et al.
patent: 2009/0304682 (2009-12-01), Hoffman et al.
patent: 2009/0317399 (2009-12-01), Pollack et al.
patent: 2010/0003243 (2010-01-01), Okun et al.
patent: 2010/0016557 (2010-01-01), Salfeld et al.
patent: 2010/0021451 (2010-01-01), Wong et al.
patent: WO9729131 (1997-08-01), None
patent: WO02/12502 (2002-02-01), None
patent: WO2006040357 (2006-04-01), None
Yang et al, Arthritis & Rheumatism, vol. 51, No. 5, 691-699, 2004.
Asli, Bouchra et al., “Inhibition of Tumor Necrosis Factor α and Ankylosing Spondyiltis,”N. Engl. J. Med., vol. 348(4):359-361 (2003).
Boeger, C.A. et al., “Treatment of ankylosing spondylitis with infliximab,”Ann. Rheum. Dis., vol. 60(12):1159-1160 (2001).
Brandt, Jan et al., “Successful Short Term Treatment of Severe Undifferentiated Spondyloarthropathy with the Anti-Tumor Necrosis Factor-α Monoclonal Antibody lnfliximab,”The Journal of Rheumatology, vol. 29(1):118-122 (2002).
Brandt, Jan et al., “Successful Treatment of Active Ankylosing Spondylitis with the Anti-tumor Necrosis Factor α Monoclonal Antibody Infliximab,”Arthritis&Rheumatism, vol. 43(6):1346-1352 (2000).
Braun, J. et al., “Anti-TNFα: a new dimension in the pharmacotherapy of the spondyloarthropathies!?,”Ann. Rheum. Dis., vol. 59(6):404-407 (2000).
Braun, J. et al., “Anti-tumour necrosis factor α therapy for ankylosing spondylitis: International experience,”Ann. Rheum. Dis., vol. 61(Suppl. III):iii51-iii60 (2002).
Braun, J. et al., “Biologic therapies in the spondyloarthritis: new opportunities, new challenges,”Curr. Opin. Rheumatol., vol. 15:394-407 (2003).
Braun, J. et al., “International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis,”Ann. Rheum. Dis., vol. 62:817-824 (2003).
Braun, Jürgen et al., “New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy,”Current Opinion in Rheumatology, vol. 13:245-249 (2001).
Braun, Juergen et al., “Novel approaches in the treatment of ankylosing spondylitis and other spondyloarthritides,”Expert Opin. Investig. Drugs, vol. 12(7):1097-1109 (2003).
Braun, J. et al., “Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years,”Rheumatology, vol. 44:670-676 (2005).
Braun, Juergen et al., “Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-α therapy and other novel approaches,”Arthritis Res., vol. 4:307-321 (2002).
Braun, J. et al., “Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial,”Lancet, vol. 359:1187-1193 (2002).
Breban, M. et al., “Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study,”Rheumatology, vol. 41:1280-1285 (2002).
Briot, K. et al., “Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment,”Ann. Rheum. Dis., vol. 64:1137-1140 (2005).
Casset, Florence et al., “A peptide mimetic of an anti-CD4 monoclonal antibody by rational design,”Biochemical and Biophysical Research Communications, vol. 307:198-205 (2003).
Cherouvim, E.P. et al., “Infliximab Therapy for Patients With Active and Refractory Spondyloarthropathies at the Dose of 3 mg/kg,”J. Clin. Rheumatol., vol. 10:162-168 (2004).
Choi, Kang-Seuk et al., “Monoclonal antibody-based competitive ELISA for simultaneous detection of rinderpest virus and peste des petits ruminants virus antibodies,”Veterinary Microbiology, vol. 96:1-16 (2003).
Davis, J.C. Jr. et al., “New therapies for ankylosing spondylitis: etanercept, thalidomide, adn pamidronate,”Rheum. Dis. Clin. North Am., vol. 29(3):481-494 (2003).
Dayer, Jean-Michel et al., “Anti-TNF-α Therapy for Ankylosing Spondylitis, a Specific or Nonspecific Treatment?”N. Engl. J. Med., vol. 346(18):1399-1400 (2002).
De Keyser, Filip et al., “Anti-TNF-alpha therapy in ank
Maksymowych Walter P.
Wong Robert L.
Abbott Biotechnology Ltd.
Cowles Cristin Howley
McCarter & English LLP
Nagle Deborah L.
Saunders David A
LandOfFree
Methods and compositions for determining the efficacy of a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for determining the efficacy of a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for determining the efficacy of a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2621398